Inventor

LI BAIYONG

CN20 patents

⚠️ This page may combine multiple inventors who share the name “LI BAIYONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LI BAIYONG

AKESO BIOPHARMA INC

Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses

Anti-PD-1/VEGFA bifunctional antibody, pharmaceutical composition thereof

Anti-IL-1β antibody and pharmaceutical composition thereof and use of same

Monoclonal antibody against nerve growth factor, and encoding gene and use thereof

Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses

Anti-CTLA4 antibodies

Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses

Anti-PD-1 monoclonal antibody

Anti-human P40 protein domain antibody and use thereof

AKESO PHARMACEUTICALS INC

Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereof

Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereof

AD PHARMACEUTICAL CO INC

PCSK9 antibody, and pharmaceutical composition and use thereof

Nucleic acid encoding PCSK9 antibody

SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD

PDL-1 antibody, pharmaceutical composition thereof, and uses thereof

PDL-1 antibody, pharmaceutical composition thereof, and uses thereof

CTTQ AKESO SHANGHAI BIOMED TECH CO LTD

Anti-PD1 monoclonal antibody, pharmaceutical composition thereof and use thereof

(unassigned)

Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

Therapeutic combination of quinoline derivative and antibody

ZEDA BIOPHARMACEUTICALS INC

Antibody binding to human IL-1β, preparation method therefor and use thereof

TAIZHOU HANZHONG BIOPHARMACEUTICS INC

Monoclonal antibody against PD-1 and application thereof